Clinical Study
Atorvastatin Combining with Probucol: A New Way to Reduce Serum Uric Acid Level during Perioperative Period of Interventional Procedure
Table 1
Baseline clinical, biochemical and procedural characteristics of the patients.
| Variable | S-C group () | I-C group () | I-A group () | value |
| Age (year) | | | | 0.616a | Female gender | 25 (45.45%) | 33 (41.72%) | 27 (36.49%) | 0.579b | Body mass index (kg/m2) | | | | 0.454a | Current smoking () | 19/34.55 | 33/41.77 | 36/48.65 | 0.274b | Total cholesterol (mmol/L) | | | | 0.592a | Triglyceride (mmol/L) | | | | 0.553a | Low-density lipoprotein (mmol/L) | | | | 0.291a | Blood glucose (mmol/L) | | | | 0.993a | Red blood cell count (1012/L) | | | | 0.116 a | White blood cell count (109/L) | | | | 0.211a | Diabetes mellitus () | 11 (20.00%) | 23 (29.11%) | 16 (21.62%) | 0.398b | Volume of contrast agent (mL) | | | | 0.993 a | Hypertension () | 38 (69.09%) | 53 (67.09%) | 49 (66.22%) | 0.548b |
|
|
Values are expressed as means ± SD or number (%) of patients. aBy Student’s test; bBy test.
|